The elevated O-GlcNAcylation and OGT expression have been involved in facilitating tumor growth and metastasis in HCC [29, 30], and the repression of OGT may be a promising treatment modality for nonalcoholic fatty liver disease [31]. This evidence concerns the gene OGT and metabolic dysfunction-associated steatotic liver disease.